Skip to main content
Clinical Trials/CTRI/2023/07/055837
CTRI/2023/07/055837
Recruiting
Phase 2

A Clinical study to evaluate efficacy and safety of Amal Tablets in the Management of Functional Constipation and Irregular Bowel Habit-An Open Label, Randomized, Comparative, Multi centric, Interventional, Prospective, Clinical Study - NI

SANDOOK SUTRAS PVT LTD0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
SANDOOK SUTRAS PVT LTD
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
SANDOOK SUTRAS PVT LTD

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects presenting with two or more of the following for the last 3 months with symptom onset at least 6 months prior to diagnosis
  • a)Straining during more than one fourth (25 percentage) of defecations
  • b)Lumpy or hard stools (Bristol Stool Form Scale 1to 2\) more than one fourth (25 percentage) of defecations
  • c)Sensation of incomplete evacuation more than one fourth (25 percentage) of defecations
  • d)Sensation of anorectal obstruction/blockage more than one fourth (25 percentage) of defecations
  • e)Manual manoeuvres to facilitate more than one fourth (25 percentage) of defecations (e.g., digital evacuation, support of the pelvic floor)
  • f)Fewer than three SBM per week
  • g) Loose stools are rarely present without the use of laxatives
  • h)Insufficient criteria for irritable bowel syndrome
  • 3\. Subjects who are ready to provide written informed consent and who are ready to willingly participate and follow the protocol requirements of the clinical study.

Exclusion Criteria

  • 1\. Subjects diagnosed with colonic inertia.
  • 2\. Subjects who have recently undergone abdominal surgery
  • 3\. Subjects with history of anorectal surgery.
  • 4\.Subjects having other functional gastrointestinal disorders other than Functional constipation (IBS, Belching disorders etc.)
  • 5\. Subjects diagnosed with structural abnormalities, like:
  • a). Anorectal: rectal prolapse, rectocele, rectal intussusceptions, anorectal stricture, solitary rectal ulcer syndrome
  • b). Perineal descent
  • c). Colonic or rectal mass or tumor with obstruction example adenocarcinoma
  • d). Colonic stricture: radiation, ischemia, diverticulosis
  • e). Intestinal obstruction.

Outcomes

Primary Outcomes

Not specified

Similar Trials